Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients

BACKGROUND: The standard of care for glioblastoma (GBM) is maximal safe resection followed by radiation therapy with chemotherapy. Currently, contrast-enhanced MRI is used to define primary treatment volumes for surgery and radiation therapy. However, enhancement does not identify the tumor entirely...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Cordova, James S., Shu, Hui-Kuo G., Liang, Zhongxing, Gurbani, Saumya S., Cooper, Lee A. D., Holder, Chad A., Olson, Jeffrey J., Kairdolf, Brad, Schreibmann, Eduard, Neill, Stewart G., Hadjipanayis, Constantinos G., Shim, Hyunsuk
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Neuroimaging
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933486/
https://ncbi.nlm.nih.gov/pubmed/26984746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now036
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars